Combination therapy of thrombosis of retinal veins with VEGF inhibitors and laser coagulation of the retina. Experience ophthalmologists Buryatia

Thrombosis of retinal veins develop due to blockage of a blood vessel by a blood clot. Often, patients lose their sight completely considerably. Central retinal vein thrombosis (CMC) as an independent disease is rare. To this pathology as a result of atherosclerosis, hypertension, diabetes, systemic vasculitis, thrombophilia and other blood diseases associated with increased clotting. CMC Ratio thrombosis up to 65-75% of all cases in the structure of the vascular pathology of the eye. In thrombosis CRV predominate defeat its branches. Currently, the modern methods of diagnosis of thrombosis CRV used. This optical coherence tomography (OCT), which allow the identification of changes in the retina (retinal edema in the macular region) in the early stages of its development, and objective evaluation of the natural flow and efficiency of the treatment. Progressive method of treating thrombosis CRV is today considered antiVEGF therapy (drugs that inhibit the vascular endothelial growth factor), developed in the early 2000s. The use of the combined approach to treatment (laser coagulation IVVL followed setchakti) retinal venous thrombosis with macular edema, improves the visual function at 0.1-0.7 and stabilize the disease process without progression of macular edema while reducing the multiplicity of repeated intravitreal injections.